Delivery Order SPE2DB22D3102-SPE2DB25FL2TZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a $35,816.03 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-patch unit). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,206.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply) on August 21, 2025, with completion scheduled for August 22, 2025. This non-competitive delivery order was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a $12,219.05 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity of 3 units). This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and completion scheduled for August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (quantity: 3 units). This firm fixed-price delivery order, valued at $10,191.60, represents a non-competitive award under an existing contract vehicle and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. The order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count package) under a firm fixed-price contract valued at $4,472.88. This non-set-aside competitive award is classified as a delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $12,138.34 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-unit package) under a firm fixed-price contract valued at $5,235.70. This non-set-aside delivery order is scheduled for ultimate completion by August 15, 2025, with fulfillment to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,377.08 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (three-count package) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2TZDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,965.60 delivery order on August 29, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and performance to be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as the primary pharmaceutical supply vehicle for federal military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare needs. The company's engagement with DLA encompasses diverse pharmaceutical products spanning multiple therapeutic domains, from specialty medications to generic drugs, vaccines, and medical supplies. This specific delivery order represents a routine transaction within the company's broader portfolio of federal medical procurement activities, demonstrating its role as a critical vendor in the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/29/25 |